BioSpace News Archive

Deals

4basebio AG announces allotment ratio and final number of shares for the share buy back

4basebio AG announces the allotment ratio and the final number of shares for the announced share buyback program.

February 25, 2020

·

3 min read

BioMidwest

Osteosarcoma profiling reveals why immunotherapy remains ineffective

Study points to strategies for improving outcomes with immunotherapy in rare cancer type

February 25, 2020

·

5 min read

BioMidwest

Recipharm names 2019 International Environmental Award winner

Recipharm has announced its 2019 International Environmental Award will be presented to Dana Kolpin, Research Hydrologist at the U.S. Geological Survey Central Midwest Water Science Center in Iowa City, Iowa.

February 25, 2020

·

4 min read

Deals

Mallinckrodt Files Chapter 11 for its Generics Business as it Reaches $1.6 Billion Opioid Settlement

In addition to the settlement and bankruptcy, Mallinckrodt entered into a debt refinancing agreement, including an $800 million loan that will be used to repay some outstanding debt and acquire some outstanding stocks.

February 25, 2020

·

3 min read

·

Alex Keown

Bio NC

RedHill Licenses AstraZeneca’s Movantik for $68 Million

Under the license deal, RedHill is paying AstraZeneca $52.5 million up front with another non-contingent payment of $15 million 18 months after the deal closes.

February 25, 2020

·

3 min read

·

Mark Terry

Novartis Shares Fall Following Post-Marketing Concerns Over AMD Drug Beovu

The ASRS issued a note to its members about concerns regarding reports of vasculitis, an inflammation of the blood vessels and other complications that can lead to the loss of vision, as a potential side effect of treatment with Beovu.

February 25, 2020

·

2 min read

·

Alex Keown

Pharm Country

Polymerase Chain Reaction (PCR) Market: Pharmaceutical & Biotechnology Industry Segment Held a Major Share of the Global Market

Rising at an impressive single digit CAGR, the global polymerase chain reaction market is predicted to attain a value of almost US$7.0 bn by 2026-end.

February 25, 2020

·

5 min read

Pharm Country

Ophthalmology Surgical Devices Market: Rising Incidence of Eye Disorders to Propel Demand, TMR

The global ophthalmology surgical devices market was valued at around US$ 7.0 Bn in 2016 and is expected to expand at a CAGR of over 4.0% from 2017 to 2025, to reach value of around US$ 11.0 Bn by 2025.

February 25, 2020

·

5 min read

Biotech Bay

Intraoperative Neuromonitoring (IONM) Market – Advanced Technologies Drive the Industry Growth

On account of the increasing care toward patient safety, the demand for intraoperative neuromonitoring has continued to rise at a steady pace.

February 25, 2020

·

4 min read

Polyphor announces progress of the Phase III immuno-oncology program with balixafortide. Renewed strategy in advancing antibiotics and oncology research and pipeline

Polyphor AG, a research based clinical stage biopharmaceutical company, announces progress of the Phase III immuno-oncology program with balixafortide and a renewed strategy in advancing antibiotics and oncology research and pipeline.

February 25, 2020

·

7 min read